20 June 2013
Keywords: nara, bio, licenses, myomouse, biosciences, biotechnology, firm
Article | 18 February 2008
Nara Biosciences, a US biotechnology firm developing therapies for muscle wasting diseases and diseases of aging, has completed an
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 February 2008
19 June 2013
© 2013 thepharmaletter.com